These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6989909)

  • 1. Interaction between Schistosoma mansoni and the complement system: binding of C1q to schistosomula.
    Santoro F; Ouaissi MA; Pestel J; Capron A
    J Immunol; 1980 Jun; 124(6):2886-91. PubMed ID: 6989909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
    Ouaissi MA; Auriault C; Santoro F; Capron A
    J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
    Santoro F; Lachmann PJ; Capron A; Capron M
    J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of IgG-Fc and C3 receptors on adult Schistosoma mansoni.
    Tarleton RL; Kemp WM
    J Immunol; 1981 Jan; 126(1):379-84. PubMed ID: 7451978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly transformed schistosomula spontaneously lose surface antigens and C3 acceptor sites during culture.
    Samuelson JC; Sher A; Caulfield JP
    J Immunol; 1980 Apr; 124(4):2055-7. PubMed ID: 6988513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae.
    Bickle QD; Ford MJ
    J Immunol; 1982 May; 128(5):2101-6. PubMed ID: 7061855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclasses of rat IgG active in the killing of schistosomula of Schistosoma mansoni in vitro and in vivo.
    Horta MF; Ramalho-Pinto FJ
    J Immunol; 1984 Dec; 133(6):3326-32. PubMed ID: 6491290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
    Hamada A; Greene BM
    J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung-stage expression of a major schistosome surface antigen.
    Aronstein WS; Strand M
    J Parasitol; 1983 Dec; 69(6):1027-32. PubMed ID: 6371211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni circulating anodic antigen but not circulating cathodic antigen interacts with complement component C1q.
    van Dam GJ; Seino J; Rotmans JP; Daha MR; Deelder AM
    Eur J Immunol; 1993 Nov; 23(11):2807-12. PubMed ID: 8223856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-mediated adherence of rat eosinophils to schistosomula of Schistoma mansoni in vitro.
    Mackenzie CD; Ramalho-Pinto FJ; McLaren DJ; Smithers SR
    Clin Exp Immunol; 1977 Oct; 30(1):97-104. PubMed ID: 606440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegument-associated antigen modulation by adult male Schistosoma mansoni.
    Kemp WM; Brown PR; Merritt SC; Miller RE
    J Immunol; 1980 Feb; 124(2):806-11. PubMed ID: 7356715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antigens and immune complexes in Schistosoma mansoni-infected rats. Characterization by radioimmunoprecipitation-PEG assay (RIPEGA).
    Santoro F; Capron M; Joseph M; Rousseaux-Prevost R; Capron A
    Clin Exp Immunol; 1978 Jun; 32(3):435-42. PubMed ID: 688695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase of Schistosoma mansoni: antigenic cross-reactivity with Electrophorus electricus and its functional implications.
    Tarrab-Hazdai R; Levi-Schaffer F; Smolarsky M; Arnon R
    Eur J Immunol; 1984 Mar; 14(3):205-9. PubMed ID: 6705822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover.
    Dean DA
    J Parasitol; 1977 Jun; 63(3):418-26. PubMed ID: 325186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.